986 related articles for article (PubMed ID: 20429644)
21. Relationship of serum TWEAK level to cytokine level, disease activity, and response to anti-TNF treatment in patients with rheumatoid arthritis.
Park MC; Chung SJ; Park YB; Lee SK
Scand J Rheumatol; 2008; 37(3):173-8. PubMed ID: 18465450
[TBL] [Abstract][Full Text] [Related]
22. C-reactive protein as a marker of periodontal disease.
Kanaparthy R; Kanaparthy A; Mahendra M
Gen Dent; 2012; 60(1):e1-5. PubMed ID: 22313986
[TBL] [Abstract][Full Text] [Related]
23. Effect of nonsurgical periodontal therapy on serum and gingival crevicular fluid cytokine levels during pregnancy and postpartum.
Fiorini T; Susin C; da Rocha JM; Weidlich P; Vianna P; Moreira CH; Bogo Chies JA; Rösing CK; Oppermann RV
J Periodontal Res; 2013 Feb; 48(1):126-33. PubMed ID: 22835005
[TBL] [Abstract][Full Text] [Related]
24. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1), and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers.
Keyszer G; Lambiri I; Nagel R; Keysser C; Keysser M; Gromnica-Ihle E; Franz J; Burmester GR; Jung K
J Rheumatol; 1999 Feb; 26(2):251-8. PubMed ID: 9972954
[TBL] [Abstract][Full Text] [Related]
25. Assessment of interleukin-6 receptor inhibition therapy on periodontal condition in patients with rheumatoid arthritis and chronic periodontitis.
Kobayashi T; Okada M; Ito S; Kobayashi D; Ishida K; Kojima A; Narita I; Murasawa A; Yoshie H
J Periodontol; 2014 Jan; 85(1):57-67. PubMed ID: 23489234
[TBL] [Abstract][Full Text] [Related]
26. Periodontal and serum protein profiles in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitor adalimumab.
Kobayashi T; Yokoyama T; Ito S; Kobayashi D; Yamagata A; Okada M; Oofusa K; Narita I; Murasawa A; Nakazono K; Yoshie H
J Periodontol; 2014 Nov; 85(11):1480-8. PubMed ID: 24857321
[TBL] [Abstract][Full Text] [Related]
27. Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-alpha in patients with chronic periodontitis.
Erdemir EO; Duran I; Haliloglu S
J Clin Periodontol; 2004 Feb; 31(2):99-104. PubMed ID: 15016034
[TBL] [Abstract][Full Text] [Related]
28. Periodontal condition of patients with autoimmune diseases and the effect of anti-tumor necrosis factor-α therapy.
Mayer Y; Elimelech R; Balbir-Gurman A; Braun-Moscovici Y; Machtei EE
J Periodontol; 2013 Feb; 84(2):136-42. PubMed ID: 22524332
[TBL] [Abstract][Full Text] [Related]
29. Salivary interleukin-1β levels in patients with chronic periodontitis before and after periodontal phase I therapy and healthy controls: a case-control study.
Kaushik R; Yeltiwar RK; Pushpanshu K
J Periodontol; 2011 Sep; 82(9):1353-9. PubMed ID: 21235331
[TBL] [Abstract][Full Text] [Related]
30. Gingival crevicular fluid MMP-8 and -13 and TIMP-1 levels in patients with rheumatoid arthritis and inflammatory periodontal disease.
Biyikoğlu B; Buduneli N; Kardeşler L; Aksu K; Pitkala M; Sorsa T
J Periodontol; 2009 Aug; 80(8):1307-14. PubMed ID: 19656031
[TBL] [Abstract][Full Text] [Related]
31. Inadequately low serum levels of steroid hormones in relation to interleukin-6 and tumor necrosis factor in untreated patients with early rheumatoid arthritis and reactive arthritis.
Straub RH; Paimela L; Peltomaa R; Schölmerich J; Leirisalo-Repo M
Arthritis Rheum; 2002 Mar; 46(3):654-62. PubMed ID: 11920401
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-1beta and thiobarbituric acid reactive substance (TBARS) levels after phase I periodontal therapy in patients with chronic periodontitis.
Tüter G; Kurtiş B; Serdar M
J Periodontol; 2001 Jul; 72(7):883-8. PubMed ID: 11495136
[TBL] [Abstract][Full Text] [Related]
33. The effects of chronic periodontitis and rheumatoid arthritis on serum and gingival crevicular fluid total antioxidant/oxidant status and oxidative stress index.
Esen C; Alkan BA; Kırnap M; Akgül O; Işıkoğlu S; Erel O
J Periodontol; 2012 Jun; 83(6):773-9. PubMed ID: 22050546
[TBL] [Abstract][Full Text] [Related]
34. Interleukin-6 gene promoter methylation in rheumatoid arthritis and chronic periodontitis.
Ishida K; Kobayashi T; Ito S; Komatsu Y; Yokoyama T; Okada M; Abe A; Murasawa A; Yoshie H
J Periodontol; 2012 Jul; 83(7):917-25. PubMed ID: 22122521
[TBL] [Abstract][Full Text] [Related]
35. Tumor necrosis factor blockade differentially affects innate inflammatory and Th17 cytokines in rheumatoid arthritis.
Zivojinovic SM; Pejnovic NN; Sefik-Bukilica MN; Kovacevic LV; Soldatovic II; Damjanov NS
J Rheumatol; 2012 Jan; 39(1):18-21. PubMed ID: 22133625
[TBL] [Abstract][Full Text] [Related]
36. Anti-TNF-alpha immunotherapy is associated with increased gingival inflammation without clinical attachment loss in subjects with rheumatoid arthritis.
Pers JO; Saraux A; Pierre R; Youinou P
J Periodontol; 2008 Sep; 79(9):1645-51. PubMed ID: 18771364
[TBL] [Abstract][Full Text] [Related]
37. Relationship between rheumatoid arthritis and periodontitis.
Mercado FB; Marshall RI; Klestov AC; Bartold PM
J Periodontol; 2001 Jun; 72(6):779-87. PubMed ID: 11453241
[TBL] [Abstract][Full Text] [Related]
38. Serum cytokines in different histological variants of rheumatoid arthritis.
Klimiuk PA; Sierakowski S; Latosiewicz R; Cylwik B; Skowronski J; Chwiecko J
J Rheumatol; 2001 Jun; 28(6):1211-7. PubMed ID: 11409111
[TBL] [Abstract][Full Text] [Related]
39. Periodontal infections contribute to elevated systemic C-reactive protein level.
Noack B; Genco RJ; Trevisan M; Grossi S; Zambon JJ; De Nardin E
J Periodontol; 2001 Sep; 72(9):1221-7. PubMed ID: 11577954
[TBL] [Abstract][Full Text] [Related]
40. Effects of periodontal therapy on disease activity and systemic inflammation in rheumatoid arthritis patients.
Erciyas K; Sezer U; Ustün K; Pehlivan Y; Kisacik B; Senyurt SZ; Tarakçioğlu M; Onat AM
Oral Dis; 2013 May; 19(4):394-400. PubMed ID: 22998534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
